报告题目：Human Longevity and Preventative Medicine
报告人：J. Craig Venter, Ph.D.
Executive Chairman and CEO, Human Longevity Inc., USA
Chairmanand CEO, J. Craig Venter Institute
Executive Chairmanand Chief Scientist, Synthetic Genomics Inc.
Dr. Venteris one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research. He earned both a Bachelor’s degree in Biochemistry and a PhD in Physiology and Pharmacology from the University of California at San Diego. He was appointed professor at the State University of New York at Buffalo and the Roswell Park Cancer Institute. In 1984, he joined the National Institutes of Health campus where he developed Expressed Sequence Tags or ESTs, a revolutionary new strategy for rapid gene discovery. In 1992, Dr. Venter founded the Institute for Genomic Research (TIGR), where he and his team decoded the genome of the first free-living organism, the bacterium Haemophilusinfluenzae, using his new whole genome shotgun technique.In 1998, Dr. Venter founded Celera Genomics to sequence the human genome using new tools and techniques he and his team developed. This research culminated with the February 2001 publication of the human genome in Science. He and his team at Celera also sequenced the fruit fly, mouse and rat genomes.
Dr. Venter is one of the most frequently cited scientists, and the author of more than 280 research articles. He is also the recipient of numerous honorary degrees, public honors, and scientific awards, including the 2008 United States National Medal of Science, the 2002 Gairdner Foundation International Award and the 2001 Paul Ehrlich and Ludwig Darmstaedter Prize. Dr. Venter is a member of numerous prestigious scientific organizations including the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Society for Microbiology.